Imatinib plasma levels are correlated with clinical benefit in patients with unresectable/metastatic gastrointestinal stromal tumors

  • George D. Demetri
  • , Yanfeng Wang
  • , Elisabeth Wehrle
  • , Amy Racine
  • , Zariana Nikolova
  • , Charles D. Blanke
  • , Heikki Joensuu
  • , Margaret Von Mehren

Research output: Contribution to journal › Article › peer-review

375 Scopus citations

Fingerprint

Dive into the research topics of 'Imatinib plasma levels are correlated with clinical benefit in patients with unresectable/metastatic gastrointestinal stromal tumors'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science